Thanks to the tools of molecular biology in general and genomics specifically, today we know more about the intricacies of cellular processes and what can go wrong to cause cancer. Investigators continue to delineate signaling pathways driving cancer development, growth, and metastasis – information which may help researchers pinpoint potential targets for novel therapies. NYU Cancer Institute investigators are at the forefront of these lines of inquiry, contributing to knowledge that may someday help people with cancer not just here in New York City, but all over the world.
Our research programs are organized as scientific research programs, which tend to focus on the fundamental biology of cancer in general, and disease-specific research programs centered on individual types of cancer, such as breast or lung cancer.
For a listing of clinical trials that are currently accruing patients, search the online clinical trials database .
Breast Cancer 
Breast cancer research to improve screening, diagnosis, and treatment for women: prevention studies, research, transitional research, clinical trials.
Brain Tumor 
The goal of the NYU Cancer Institute brain tumor research program is to identify more effective therapies that extend survival for patients with these diseases.
Cancer Immunology 
Research toward developing treatments for neoplasms arising from lymphoid and myeloid system cells, understanding the biology of tumor rejection, promoting tumor immunotherapy.
Colorectal Cancer 
NYUCI investigators are leading innovative laboratory research to predict how and why colorectal cancer spreads, and evaluating novel treatment combinations aimed at slowing cancer growth.
Environmental & Molecular Carcinogenesis 
Cancer research for the study and prevention of environmental chemical and physical carcinogenesis
Epidemiology And Cancer Control 
The mission of investigators in the field of population sciences is to reduce the risk, incidence, and deaths from cancer as well as to enhance the quality of life of cancer survivors.
Genitourinary Cancer 
Research of genitourinary cancer (prostate and bladder cancer): diagnosis and testing methods, stem cell research, genetics, animal models, improved chemopreventive agents and cancer treatment methods.
Growth Control 
Bench research and translational research to understand the neoplastic process and develop improved and targeted cancer drugs.
Lymphomas are divided into two large groups of diseases often referred to as non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (sometimes called Hodgkin lymphoma).
The NYUCI Melanoma Research Program focuses its research efforts on the pathogenesis, diagnosis, and treatment of melanoma.
Our goal is to improve the outcome of patients with multiple myeloma using targeted therapies that will have greater effectiveness and fewer side effects than conventional approaches.
Pancreatic Cancer 
Scientists at the NYU Cancer Institute are seeking to delineate the cellular and molecular basis of pancreatic cancer and the role of the immune response in its initiation and progression.
Although sarcomas are not nearly as common as cancers of the breast, prostate, colon, or lung, they often strike people in the prime of life - particularly children, adolescents, and young adults.
Stem Cell Biology 
Investigations into the biology of animal stem cells to create targeted treatment methods for human cancer.
Thoracic Cancer 
Lung cancer remains the leading cause of cancer death in the United States, claiming nearly 160,000 lives annually.